Tolerance Through Education: How Tolerogenic Dendritic Cells Shape Immunity

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2018 Jan 30

PMID 29375543

Citations 100

Authors

Matthias P Domogalla

Patricia V Rostan

Verena K Raker

Kerstin Steinbrink

Affiliations

Soon will be listed here.

Abstract

Dendritic cells (DCs) are central players in the initiation and control of responses, regulating the balance between tolerance and immunity. Tolerogenic DCs are essential in the maintenance of central and peripheral tolerance by induction of clonal T cell deletion and T cell anergy, inhibition of memory and effector T cell responses, and generation and activation of regulatory T cells. Therefore, tolerogenic DCs are promising candidates for specific cellular therapy of allergic and autoimmune diseases and for treatment of transplant rejection. Studies performed in rodents have demonstrated the efficacy and feasibility of tolerogenic DCs for tolerance induction in various inflammatory diseases. In the last years, numerous protocols for the generation of human monocyte-derived tolerogenic DCs have been established and some first phase I trials have been conducted in patients suffering from autoimmune disorders, demonstrating the safety and efficiency of this cell-based immunotherapy. This review gives an overview about methods and protocols for the generation of human tolerogenic DCs and their mechanisms of tolerance induction with the focus on interleukin-10-modulated DCs. In addition, we will discuss the prerequisites for optimal clinical grade tolerogenic DC subsets and results of clinical trials with tolerogenic DCs in autoimmune diseases.

Citing Articles

RAD001-mediated mTOR targeting in human monocyte-derived dendritic cells shifts them toward an immunogenic phenotype.

Naseri B, Alipour S, Masoumi J, Hatami-Sadr A, Vaysi E, Hemmat N Immunol Res. 2024; 73(1):21.

PMID: 39699830 DOI: 10.1007/s12026-024-09572-8.

Comprehensive macro and micro views on immune cells in ischemic heart disease.

Zhao Y, Tan M, Yin Y, Zhang J, Song Y, Li H Cell Prolif. 2024; 57(12):e13725.

PMID: 39087342 PMC: 11628753. DOI: 10.1111/cpr.13725.

High expression of PD-L1 on conventional dendritic cells in tumour-draining lymph nodes is associated with poor prognosis in oral cancer.

Eric H, Piersiala K, Lagebro V, Farrajota Neves da Silva P, Petro M, Starkhammar M Cancer Immunol Immunother. 2024; 73(9):165.

PMID: 38954023 PMC: 11219651. DOI: 10.1007/s00262-024-03754-x.

PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.

Choi J, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y Nat Commun. 2024; 15(1):5487.

PMID: 38942798 PMC: 11213953. DOI: 10.1038/s41467-024-48931-9.

Sub-acute oral exposure to lowest observed adverse effect level of nivalenol exacerbates atopic dermatitis in mice via direct activation of mitogen-activated protein kinase signal in antigen-presenting cells.

Matsuzaka R, Yamaguchi H, Ohira C, Kurita T, Iwashita N, Takagi Y Arch Toxicol. 2024; 98(7):2173-2183.

PMID: 38616237 DOI: 10.1007/s00204-024-03740-3.

References

Akbari O, DeKruyff R, Umetsu D . Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol. 2001; 2(8):725-31. DOI: 10.1038/90667. View

Wakkach A, Fournier N, Brun V, Breittmayer J, Cottrez F, Groux H . Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 2003; 18(5):605-17. DOI: 10.1016/s1074-7613(03)00113-4. View

Munn D, Sharma M, Lee J, Jhaver K, Johnson T, Keskin D . Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002; 297(5588):1867-70. DOI: 10.1126/science.1073514. View

Perry J, Lio C, Kau A, Nutsch K, Yang Z, Gordon J . Distinct contributions of Aire and antigen-presenting-cell subsets to the generation of self-tolerance in the thymus. Immunity. 2014; 41(3):414-426. PMC: 4175925. DOI: 10.1016/j.immuni.2014.08.007. View

Hirata S, Senju S, Matsuyoshi H, Fukuma D, Uemura Y, Nishimura Y . Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. J Immunol. 2005; 174(4):1888-97. DOI: 10.4049/jimmunol.174.4.1888. View

Kubsch S, Graulich E, Knop J, Steinbrink K . Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1. Eur J Immunol. 2003; 33(7):1988-97. DOI: 10.1002/eji.200323600. View

Unger W, Laban S, Kleijwegt F, van der Slik A, Roep B . Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1. Eur J Immunol. 2009; 39(11):3147-59. DOI: 10.1002/eji.200839103. View

Maldonado R, von Andrian U . How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol. 2010; 108:111-65. PMC: 3050492. DOI: 10.1016/B978-0-12-380995-7.00004-5. View

Yates S, Paterson A, Nolan K, Cobbold S, Saunders N, Waldmann H . Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol. 2007; 179(2):967-76. DOI: 10.4049/jimmunol.179.2.967. View

10.

Benham H, Nel H, Law S, Mehdi A, Street S, Ramnoruth N . Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci Transl Med. 2015; 7(290):290ra87. DOI: 10.1126/scitranslmed.aaa9301. View

11.

Kurts C, Heath W, Kosaka H, Miller J, Carbone F . The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med. 1998; 188(2):415-20. PMC: 2212451. DOI: 10.1084/jem.188.2.415. View

12.

Horibe E, Sacks J, Unadkat J, Raimondi G, Wang Z, Ikeguchi R . Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl Immunol. 2007; 18(4):307-18. DOI: 10.1016/j.trim.2007.10.007. View

13.

Guilliams M, Ginhoux F, Jakubzick C, Naik S, Onai N, Schraml B . Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat Rev Immunol. 2014; 14(8):571-8. PMC: 4638219. DOI: 10.1038/nri3712. View

14.

Mellor A, Munn D . IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004; 4(10):762-74. DOI: 10.1038/nri1457. View

15.

Wu J, Horuzsko A . Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells. Hum Immunol. 2009; 70(5):353-6. PMC: 2775504. DOI: 10.1016/j.humimm.2009.01.024. View

16.

Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig M, von Boehmer H . Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005; 6(12):1219-27. DOI: 10.1038/ni1265. View

17.

Keir M, Francisco L, Sharpe A . PD-1 and its ligands in T-cell immunity. Curr Opin Immunol. 2007; 19(3):309-14. DOI: 10.1016/j.coi.2007.04.012. View

18.

Hsu P, Santner-Nanan B, Hu M, Skarratt K, Lee C, Stormon M . IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1. J Immunol. 2015; 195(8):3665-74. DOI: 10.4049/jimmunol.1402898. View

19.

Gagliani N, Magnani C, Huber S, Gianolini M, Pala M, Licona-Limon P . Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013; 19(6):739-46. DOI: 10.1038/nm.3179. View

20.

Anderson A, Swan D, Wong O, Buck M, Eltherington O, Harry R . Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4 T cells partly via transforming growth factor-β1. Clin Exp Immunol. 2016; 187(1):113-123. PMC: 5167049. DOI: 10.1111/cei.12870. View